{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:21:44Z","timestamp":1778851304177,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Promotionskolleg of the University Medical Center G\u00f6ttingen"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZE524\/2-3"],"award-info":[{"award-number":["ZE524\/2-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung","doi-asserted-by":"publisher","award":["MD23"],"award-info":[{"award-number":["MD23"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Aortic stenosis (AS) is one of the most common cardiac diseases and major cause of morbidity and mortality in the elderly. Transcatheter aortic valve implantation (TAVI) is performed in such patients with symptomatic severe AS and reduces mortality for the majority of these patients. However, a significant percentage dies within the first two years after TAVI, such that there is an interest to identify parameters, which predict outcome and could guide pre-TAVI patient selection. High levels of cardiac fibrosis have been identified as such independent predictor of cardiovascular mortality after TAVI. Promoter hypermethylation commonly leads to gene downregulation, and the Iroquois homeobox 3 (IRX3) gene was identified in a genome-wide transcriptome and methylome to be hypermethylated and downregulated in AS patients. In a well-described cohort of 100 TAVI patients in which cardiac fibrosis levels were quantified histologically in cardiac biopsies, and which had a follow-up of up to two years, we investigated if circulating methylated DNA of <jats:italic>IRX3<\/jats:italic> in the peripheral blood is associated with cardiac fibrosis and\/or mortality in AS patients undergoing TAVI and thus could serve as a biomarker to add information on outcome after TAVI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients with high levels of methylation in circulating <jats:italic>IRX3<\/jats:italic> show a significantly increased survival as compared to patients with low levels of <jats:italic>IRX3<\/jats:italic> methylation indicating that high peripheral <jats:italic>IRX3<\/jats:italic> methylation is associated with an improved outcome. In the multivariable setting, peripheral <jats:italic>IRX3<\/jats:italic> methylation acts as an independent predictor of all-cause mortality. While there is no significant correlation of levels of <jats:italic>IRX3<\/jats:italic> methylation with cardiac death, there is a significant but very weak inverse correlation between circulating <jats:italic>IRX3<\/jats:italic> promoter methylation level and the amount of cardiac fibrosis. Higher levels of peripheral <jats:italic>IRX3<\/jats:italic> methylation further correlated with decreased cardiac IRX3 expression and vice versa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>High levels of <jats:italic>IRX3<\/jats:italic> methylation in the blood of AS patients at the time of TAVI are associated with better overall survival after TAVI and at least partially reflect myocardial IRX3 expression. Circulating methylated <jats:italic>IRX3<\/jats:italic> might aid as a potential biomarker to help guide both pre-TAVI patient selection and post-TAVI monitoring.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13148-023-01561-2","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T17:01:57Z","timestamp":1694451717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low levels of circulating methylated IRX3 are related to worse outcome after transcatheter aortic valve implantation in patients with severe aortic stenosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Leon","family":"Kanwischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afifa Binta","family":"Saifuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Maamari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouzi","family":"Alnour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Tampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Zeisberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Hasenfuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Puls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M.","family":"Zeisberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"issue":"6","key":"1561_CR1","first-page":"396","volume":"99","author":"GW Eveborn","year":"2013","unstructured":"Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. Troms\u00f8 Study Heart. 2013;99(6):396\u2013400.","journal-title":"Troms\u00f8 Study Heart"},{"issue":"4","key":"1561_CR2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"BH Lorell","year":"2000","unstructured":"Lorell BH, Carabello BA. Left ventricular hypertrophy. Circulation. 2000;102(4):470\u20139.","journal-title":"Circulation"},{"issue":"7","key":"1561_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS). Eur Heart J. 2022;43(7):561\u2013632.","journal-title":"Eur Heart J"},{"issue":"3","key":"1561_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejheart.2004.01.008","volume":"6","author":"P Bettencourt","year":"2004","unstructured":"Bettencourt P. NT-proBNP and BNP: biomarkers for heart failure management. Eur J Heart Fail. 2004;6(3):359\u201363.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"1561_CR5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1503\/cmaj\/051291","volume":"173","author":"L Babuin","year":"2005","unstructured":"Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ. 2005;173(10):1191\u2013202.","journal-title":"CMAJ"},{"issue":"19","key":"1561_CR6","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jacc.2014.02.581","volume":"63","author":"MA Clavel","year":"2014","unstructured":"Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, et al. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J Am Coll Cardiol. 2014;63(19):2016\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1561_CR7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13148-017-0406-7","volume":"9","author":"I Go\u0161ev","year":"2017","unstructured":"Go\u0161ev I, Zeljko M, \u0110uri\u0107 \u017d, Nikoli\u0107 I, Go\u0161ev M, Iv\u010devi\u0107 S, et al. Epigenome alterations in aortic valve stenosis and its related left ventricular hypertrophy. Clin Epigenetics. 2017;9(1):106.","journal-title":"Clin Epigenetics"},{"issue":"20","key":"1561_CR8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/eurheartj\/ehaa033","volume":"41","author":"M Puls","year":"2020","unstructured":"Puls M, Beuthner BE, Topci R, Vogelgesang A, Bleckmann A, Sitte M, et al. Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis. Eur Heart J. 2020;41(20):1903\u201314.","journal-title":"Eur Heart J"},{"issue":"2","key":"1561_CR9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2018.11.026","volume":"12","author":"R Bing","year":"2019","unstructured":"Bing R, Cavalcante JL, Everett RJ, Clavel MA, Newby DE, Dweck MR. Imaging and impact of myocardial fibrosis in aortic stenosis. JACC Cardiovasc Imaging. 2019;12(2):283\u201396.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"1561_CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-genet-120213-092518","volume":"48","author":"E Brookes","year":"2014","unstructured":"Brookes E, Shi Y. Diverse epigenetic mechanisms of human disease. Annu Rev Genet. 2014;48(1):237\u201368.","journal-title":"Annu Rev Genet"},{"issue":"2","key":"1561_CR11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/cbic.201000195","volume":"12","author":"RZ Jurkowska","year":"2011","unstructured":"Jurkowska RZ, Jurkowski TP, Jeltsch A. Structure and function of mammalian DNA methyltransferases. ChemBioChem. 2011;12(2):206\u201322.","journal-title":"ChemBioChem"},{"issue":"4","key":"1561_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.stem.2013.02.005","volume":"12","author":"Y Gao","year":"2013","unstructured":"Gao Y, Chen J, Li K, Wu T, Huang B, Liu W, et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell. 2013;12(4):453\u201369.","journal-title":"Cell Stem Cell"},{"issue":"5929","key":"1561_CR13","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930\u20135.","journal-title":"Science"},{"issue":"210","key":"1561_CR14","doi-asserted-by":"crossref","first-page":"107514","DOI":"10.1016\/j.pharmthera.2020.107514","volume":"1","author":"C Schiano","year":"2020","unstructured":"Schiano C, Benincasa G, Franzese M, Della Mura N, Pane K, Salvatore M, et al. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases. Pharmacol Ther. 2020;1(210):107514.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"1561_CR15","doi-asserted-by":"crossref","first-page":"e0154010","DOI":"10.1371\/journal.pone.0154010","volume":"11","author":"U Radhakrishna","year":"2016","unstructured":"Radhakrishna U, Albayrak S, Alpay-Savasan Z, Zeb A, Turkoglu O, Sobolewski P, et al. Genome-wide DNA methylation analysis and epigenetic variations associated with congenital aortic valve stenosis (AVS). PLoS ONE. 2016;11(5):e0154010.","journal-title":"PLoS ONE"},{"issue":"1","key":"1561_CR16","doi-asserted-by":"crossref","first-page":"e002649","DOI":"10.1161\/CIRCGEN.119.002649","volume":"13","author":"T Nasu","year":"2020","unstructured":"Nasu T, Satoh M, Ohmomo H, Shiwa Y, Komaki S, Ono K, et al. Epigenome-wide association study identifies a novel DNA methylation in patients with severe aortic valve stenosis. Circ Genom Precis Med. 2020;13(1):e002649.","journal-title":"Circ Genom Precis Med"},{"issue":"6","key":"1561_CR17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1561_CR18","first-page":"1659","volume":"61","author":"S Jahr","year":"2001","unstructured":"Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61(4):1659\u201365.","journal-title":"Cancer Res"},{"issue":"1","key":"1561_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2000.tb06608.x","volume":"906","author":"M Stroun","year":"2000","unstructured":"Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, et al. The origin and mechanism of circulating DNA. Ann N Y Acad Sci. 2000;906(1):161\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"1561_CR20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1099800416642571","volume":"18","author":"MO Frank","year":"2016","unstructured":"Frank MO. Circulating cell-free DNA differentiates severity of inflammation. Biol Res Nurs. 2016;18(5):477\u201388.","journal-title":"Biol Res Nurs"},{"issue":"6","key":"1561_CR21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cjca.2019.10.016","volume":"36","author":"T Yokokawa","year":"2020","unstructured":"Yokokawa T, Misaka T, Kimishima Y, Shimizu T, Kaneshiro T, Takeishi Y. Clinical significance of circulating cardiomyocyte-specific cell-free DNA in patients with heart failure: a proof-of-concept study. Can J Cardiol. 2020;36(6):931\u20135.","journal-title":"Can J Cardiol"},{"issue":"9","key":"1561_CR22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jclinpath-2019-206404","volume":"73","author":"G Mansueto","year":"2020","unstructured":"Mansueto G, Benincasa G, Della Mura N, Nicoletti GF, Napoli C. Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs. J Clin Pathol. 2020;73(9):535\u201343.","journal-title":"J Clin Pathol"},{"issue":"2","key":"1561_CR23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1253\/circj.CJ-19-0879","volume":"84","author":"G Benincasa","year":"2020","unstructured":"Benincasa G, Marfella R, Della Mura N, Schiano C, Napoli C. Strengths and opportunities of network medicine in cardiovascular diseases. Circ J. 2020;84(2):144\u201352.","journal-title":"Circ J"},{"issue":"224","key":"1561_CR24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2020.03.007","volume":"1","author":"C Napoli","year":"2020","unstructured":"Napoli C, Benincasa G, Donatelli F, Ambrosio G. Precision medicine in distinct heart failure phenotypes: focus on clinical epigenetics. Am Heart J. 2020;1(224):113\u201328.","journal-title":"Am Heart J"},{"issue":"4","key":"1561_CR25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)80853-3","volume":"101","author":"J Briscoe","year":"2000","unstructured":"Briscoe J, Pierani A, Jessell TM, Ericson J. A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell. 2000;101(4):435\u201345.","journal-title":"Cell"},{"issue":"1","key":"1561_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0092-8674(02)00678-5","volume":"109","author":"QR Lu","year":"2002","unstructured":"Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, et al. Common developmental requirement for olig function indicates a motor neuron\/oligodendrocyte connection. Cell. 2002;109(1):75\u201386.","journal-title":"Cell"},{"issue":"7492","key":"1561_CR27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature13138","volume":"507","author":"S Smemo","year":"2014","unstructured":"Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, G\u00f3mez-Mar\u00edn C, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507(7492):371\u20135.","journal-title":"Nature"},{"issue":"21","key":"1561_CR28","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1242\/dev.081703","volume":"139","author":"N Gaborit","year":"2012","unstructured":"Gaborit N, Sakuma R, Wylie JN, Kim KH, Zhang SS, Hui CC, et al. Cooperative and antagonistic roles for Irx3 and Irx5 in cardiac morphogenesis and postnatal physiology. Development. 2012;139(21):4007\u201319.","journal-title":"Development"},{"issue":"1","key":"1561_CR29","doi-asserted-by":"crossref","first-page":"19197","DOI":"10.1038\/srep19197","volume":"6","author":"KH Kim","year":"2016","unstructured":"Kim KH, Rosen A, Hussein SMI, Puviindran V, Korogyi AS, Chiarello C, et al. Irx3 is required for postnatal maturation of the mouse ventricular conduction system. Sci Rep. 2016;6(1):19197.","journal-title":"Sci Rep"},{"issue":"18","key":"1561_CR30","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/eurheartj\/ehv449","volume":"37","author":"A Koizumi","year":"2015","unstructured":"Koizumi A, Sasano T, Kimura W, Miyamoto Y, Aiba T, Ishikawa T, et al. Genetic defects in a His-Purkinje system transcription factor, IRX3, cause lethal cardiac arrhythmias. Eur Heart J. 2015;37(18):1469\u201375.","journal-title":"Eur Heart J"},{"issue":"3","key":"1561_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/cvr\/cvv015","volume":"105","author":"X Xu","year":"2015","unstructured":"Xu X, Tan X, Tampe B, Nyamsuren G, Liu X, Maier LS, et al. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis. Cardiovasc Res. 2015;105(3):279\u201391.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"1561_CR32","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1128\/MCB.22.9.3157-3173.2002","volume":"22","author":"M Curradi","year":"2002","unstructured":"Curradi M, Izzo A, Badaracco G, Landsberger N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol. 2002;22(9):3157\u201373.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1561_CR33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s41467-018-03961-y","volume":"9","author":"H Zemmour","year":"2018","unstructured":"Zemmour H, Planer D, Magenheim J, Moss J, Neiman D, Gilon D, et al. Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA. Nat Commun. 2018;9(1):1443.","journal-title":"Nat Commun"},{"key":"1561_CR34","doi-asserted-by":"crossref","first-page":"840647","DOI":"10.3389\/fcvm.2022.840647","volume":"9","author":"S Halawa","year":"2022","unstructured":"Halawa S, Latif N, Tseng YT, Ibrahim AM, Chester AH, Moustafa A, et al. Profiling Genome-Wide DNA Methylation Patterns in Human Aortic and Mitral Valves. Front Cardiovasc Med. 2022;9:840647.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"1561_CR35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.108.847772","volume":"120","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Herrmann S, St\u00f6rk S, Niemann M, Frantz S, Lange V, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009;120(7):577\u201384.","journal-title":"Circulation"},{"issue":"12","key":"1561_CR36","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","volume":"58","author":"MR Dweck","year":"2011","unstructured":"Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58(12):1271\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1561_CR37","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jtcvs.2011.11.024","volume":"144","author":"AD Milano","year":"2012","unstructured":"Milano AD, Faggian G, Dodonov M, Golia G, Tomezzoli A, Bortolotti U, et al. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. J Thorac Cardiovasc Surg. 2012;144(4):830\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"1561_CR38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ehf2.12451","volume":"6","author":"A Galat","year":"2019","unstructured":"Galat A, Guellich A, Bodez D, Lipskaia L, Moutereau S, Bergoend E, et al. Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement. ESC Heart Fail. 2019;6(4):649\u201357.","journal-title":"ESC Heart Fail"},{"issue":"16","key":"1561_CR39","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jcin.2022.06.019","volume":"15","author":"L Minten","year":"2022","unstructured":"Minten L, Wissels P, McCutcheon K, Bennett J, Adriaenssens T, Desmet W, et al. The effect of coronary lesion complexity and preprocedural revascularization on\u00a05-year outcomes after TAVR. JACC Cardiovasc Interv. 2022;15(16):1611\u201320.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"1561_CR40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1912846","volume":"382","author":"DH Kang","year":"2020","unstructured":"Kang DH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK, et al. Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med. 2020;382(2):111\u20139.","journal-title":"N Engl J Med"},{"issue":"11","key":"1561_CR41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00392-013-0596-8","volume":"102","author":"A Sedaghat","year":"2013","unstructured":"Sedaghat A, Sinning JM, Vasa-Nicotera M, Ghanem A, Hammerstingl C, Grube E, et al. The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol. 2013;102(11):821\u20139.","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"1561_CR42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jjcc.2020.02.019","volume":"76","author":"RA Spampinato","year":"2020","unstructured":"Spampinato RA, Bochen R, Sieg F, Weiss S, Kornej J, Haunschild J, et al. Multi-biomarker mortality prediction in patients with aortic stenosis undergoing valve replacement. J Cardiol. 2020;76(2):154\u201362.","journal-title":"J Cardiol"},{"issue":"12","key":"1561_CR43","doi-asserted-by":"crossref","first-page":"e48851","DOI":"10.1371\/journal.pone.0048851","volume":"7","author":"J Parenica","year":"2012","unstructured":"Parenica J, Nemec P, Tomandl J, Ondrasek J, Pavkova-Goldbergova M, Tretina M, et al. Prognostic utility of biomarkers in predicting of one-year outcomes in patients with aortic stenosis treated with transcatheter or surgical aortic valve implantation. PLoS ONE. 2012;7(12):e48851.","journal-title":"PLoS ONE"},{"issue":"2","key":"1561_CR44","first-page":"29","volume":"9","author":"M White","year":"2021","unstructured":"White M, Baral R, Ryding A, Tsampasian V, Ravindrarajah T, Garg P, et al. Biomarkers associated with mortality in aortic stenosis: a systematic review and meta-analysis. Med Sci (Basel). 2021;9(2):29.","journal-title":"Med Sci (Basel)"},{"issue":"6","key":"1561_CR45","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.ijcard.2012.07.021","volume":"167","author":"AV Villar","year":"2013","unstructured":"Villar AV, Garc\u00eda R, Merino D, Llano M, Cobo M, Montalvo C, et al. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol. 2013;167(6):2875\u201381.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1561_CR46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12265-022-10294-1","volume":"16","author":"G Benincasa","year":"2023","unstructured":"Benincasa G, Maron BA, Affinito O, D\u2019Alto M, Franzese M, Argiento P, et al. Association between circulating CD4(+) T cell methylation signatures of network-oriented SOCS3 gene and hemodynamics in patients suffering pulmonary arterial hypertension. J Cardiovasc Transl Res. 2023;16(1):17\u201330.","journal-title":"J Cardiovasc Transl Res"},{"issue":"8","key":"1561_CR47","doi-asserted-by":"crossref","first-page":"e0236951","DOI":"10.1371\/journal.pone.0236951","volume":"15","author":"C Schiano","year":"2020","unstructured":"Schiano C, Benincasa G, Infante T, Franzese M, Castaldo R, Fiorito C, et al. Integrated analysis of DNA methylation profile of HLA-G gene and imaging in coronary heart disease: pilot study. PLoS ONE. 2020;15(8):e0236951.","journal-title":"PLoS ONE"},{"issue":"1","key":"1561_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccl.2019.09.010","volume":"38","author":"KH Zheng","year":"2020","unstructured":"Zheng KH, Tzolos E, Dweck MR. Pathophysiology of aortic stenosis and future perspectives for medical therapy. Cardiol Clin. 2020;38(1):1\u201312.","journal-title":"Cardiol Clin"},{"issue":"35","key":"1561_CR49","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","volume":"21","author":"M Esteller","year":"2002","unstructured":"Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21(35):5427\u201340.","journal-title":"Oncogene"},{"issue":"1","key":"1561_CR50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1074248415591698","volume":"21","author":"CJ Watson","year":"2016","unstructured":"Watson CJ, Horgan S, Neary R, Glezeva N, Tea I, Corrigan N, et al. Epigenetic therapy for the treatment of hypertension-induced cardiac hypertrophy and fibrosis. J Cardiovasc Pharmacol Ther. 2016;21(1):127\u201337.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"1561_CR51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.kint.2016.07.042","volume":"91","author":"B Tampe","year":"2017","unstructured":"Tampe B, Steinle U, Tampe D, Carstens JL, Korsten P, Zeisberg EM, et al. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury\u2013to\u2013chronic kidney disease progression. Kidney Int. 2017;91(1):157\u201376.","journal-title":"Kidney Int"},{"issue":"1","key":"1561_CR52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-022-01055-2","volume":"7","author":"Y Shi","year":"2022","unstructured":"Shi Y, Zhang H, Huang S, Yin L, Wang F, Luo P, et al. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2022;7(1):200.","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"1561_CR53","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","volume":"33","author":"AP Kappetein","year":"2012","unstructured":"Kappetein AP, Head SJ, G\u00e9n\u00e9reux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. Eur Heart J. 2012;33(19):2403\u201318.","journal-title":"Eur Heart J"},{"issue":"8","key":"1561_CR54","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/15384047.2019.1598759","volume":"20","author":"A Kustanovich","year":"2019","unstructured":"Kustanovich A, Schwartz R, Peretz T, Grinshpun A. Life and death of circulating cell-free DNA. Cancer Biol Ther. 2019;20(8):1057\u201367.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1561_CR55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1196\/annals.1318.034","volume":"1022","author":"PP Laktionov","year":"2004","unstructured":"Laktionov PP, Tamkovich SN, Rykova EYu, Bryzgunova OE, Starikov AV, Kuznetsova NP, et al. Cell-surface-bound nucleic acids: free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients. Ann N Y Acad Sci. 2004;1022(1):221\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"1561_CR56","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1373\/clinchem.2004.045062","volume":"51","author":"SN Tamkovich","year":"2005","unstructured":"Tamkovich SN, Bryzgunova OE, Rykova EY, Permyakova VI, Vlassov VV, Laktionov PP. Circulating nucleic acids in blood of healthy male and female donors. Clin Chem. 2005;51(7):1317\u20139.","journal-title":"Clin Chem"},{"issue":"16","key":"1561_CR57","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.117.027355","volume":"136","author":"B Meder","year":"2017","unstructured":"Meder B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Frese K, Lai A, et al. Epigenome-wide association study identifies cardiac gene patterning and a novel class of biomarkers for heart failure. Circulation. 2017;136(16):1528\u201344.","journal-title":"Circulation"},{"issue":"7","key":"1561_CR58","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-023-01561-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-023-01561-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-023-01561-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T05:34:47Z","timestamp":1700544887000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-023-01561-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1186\/s13148-023-01561-2","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"assertion":[{"value":"15 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the University Medical Center G\u00f6ttingen approved the study (application number: 10\/5\/16), and informed consent was obtained from each patient. All procedures were performed conforming to the World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}